| Income Statement | 2025-09-30 | |||
|---|---|---|---|---|
| Research and development expenses-Nonrelated Party | 31 | |||
| Research and development expenses-Related Party | 115 | |||
| Marketing, general and administrative expenses-Related Party | 202 | |||
| Marketing, general and administrative expenses-Nonrelated Party | 29 | |||
| Operating loss | -377 | |||
| Other financing expenses, net | -9 | |||
| Financing income (expenses), net | -9 | |||
| Net loss attributable to common stockholders | -386 | |||
| Other comprehensive income loss attributable to foreign currency translation | -30 | |||
| Comprehensive loss | -356 | |||
| Basic weighted average number of shares of common stock outstanding | 1,234,185,009 | |||
| Loss per common stock, basic | 0 | |||
| Loss per common stock, diluted | 0 | |||
CITRINE GLOBAL, CORP. (CTGL)
CITRINE GLOBAL, CORP. (CTGL)